$17.19
1.66% day before yesterday
Nasdaq, Sep 06, 10:00 pm CET
ISIN
US74587B1017
Symbol
PLSE

Pulse Biosciences, Inc. Stock price

$17.19
+3.15 22.44% 1M
+7.89 84.74% 6M
+4.95 40.44% YTD
+12.36 255.90% 1Y
-7.61 30.69% 3Y
+4.38 34.19% 5Y
+13.02 312.23% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
-0.29 1.66%
ISIN
US74587B1017
Symbol
PLSE
Sector

Key metrics

Market capitalization $1.05b
Enterprise Value $1.04b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 35.20
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-46.13m
Free Cash Flow (TTM) Free Cash Flow $-35.54m
Cash position $26.20m
EPS (TTM) EPS $-0.79
Short interest 15.03%
Show more

Is Pulse Biosciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Pulse Biosciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Pulse Biosciences, Inc.:

1x Hold
100%

Analyst Opinions

1 Analyst has issued a forecast Pulse Biosciences, Inc.:

Hold
100%

Financial data from Pulse Biosciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
- -
-
100%
- Direct Costs 1.14 1.14
90% 90%
-
-1.14 -1.14
90% 90%
-
- Selling and Administrative Expenses 15 15
10% 10%
-
- Research and Development Expense 29 29
39% 39%
-
-45 -45
1% 1%
-
- Depreciation and Amortization 1.14 1.14
11% 11%
-
EBIT (Operating Income) EBIT -46 -46
1% 1%
-
Net Profit -44 -44
6% 6%
-

In millions USD.

Don't miss a Thing! We will send you all news about Pulse Biosciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pulse Biosciences, Inc. Stock News

Neutral
InvestorPlace
16 days ago
Pulse Biosciences (NASDAQ: PLSE ) just reported results for the second quarter of 2024. Pulse Biosciences reported earnings per share of -20 cents.
Neutral
Seeking Alpha
26 days ago
Pulse Biosciences Inc. (NASDAQ:PLSE ) Q2 2024 Earnings Conference Call August 12, 2024 4:30 PM ET Company Participants Philip Taylor - Investor Relations Burke Barrett - President & CEO Michael Koffler - VP of Finance Conference Call Participants Anthony Petrone - Mizuho Group Operator Greetings, and welcome to the Second Quarter 2024 Financial Results Conference Call. At this time, all partici...
Neutral
Business Wire
26 days ago
MIAMI--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA) technology, today announced business updates and preliminary financial results for the second quarter ended June 30, 2024. Recent Business Highlights Soft Tissue Ablation Completed the first procedure w...
More Pulse Biosciences, Inc. News

Company Profile

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.

Head office United States
CEO Burke Barrett
Employees 56
Founded 2014
Website www.pulsebiosciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today